Fungal infections in BM transplant patients are being seen with greater frequency than ever before. The most common fungal organisms isolated are Candida, followed by the Aspergillus species. In addition, a growing list of unusual and unexpected etiological agents presents a unique and difficult challenge to clinicians and microbiologists. Aureobasidium is a demataceous fungus commonly isolated from soil and the indoor air environment. This genus includes 14 species, among which, Aureobasidium pullulans is the only well-known pathogen causing s.c. infection or phaehyphomycosis. 1 We report a case of systemic A. pullulans infection during the first week of allogeneic stem cell transplant.
We present here the case of an 11-year-old boy, who was diagnosed with Fanconi's anemia in August 2007 and had undergone a matched sibling BM transplant in January 2008. He rejected this graft within 7 months of transplant. A second allogeneic peripheral blood stem cell transplant was performed in September 2008 using the same donor. The conditioning regimen used during the second transplant was fludarabine (30 mg/m 2 i.v.) once daily from day À7 to day À3, BU (1 mg/kg per oral (p.o.)) 6 hourly from day À6 to day À4 and horse anti-thymocyte globulin (20 mg/kg i.v.) once daily from day À4 to À2. He was on itraconazole prophylaxis and had no evidence of fungal infection before the second transplant. The patient developed fever with erythematous papules over the right forearm, both distal lower limbs and swelling in small joints of the hand on day 0 of the second transplant ( Figure 1 ). The patient was started on a broad spectrum of antibiotics the same day. However, in view of the progressive increase in size and number of skin lesions over the next 2 days, the patient was started on voriconazole by injection on day þ 3 with a clinical suspicion of candidemia. A blood culture from the central venous catheter lumen was initially suggestive of growth of a yeast-like organism, hence the catheter was removed. Chest X-ray was normal. Further evaluation of the blood culture showed multicellular filamentous hyphae of varying sizes accompanied by budding yeast-like cells, both in the BACTEC 9050 (Becton Dickinson, Franklin Lakes, NJ, USA) and in the colonies growing on Sabouraud's dextrose agar media (Hi-Media, Mumbai, India). These fungal isolates were subsequently classified as A. pullulans because of their classical pigment production (Figure 2a) . A skin biopsy carried out on day þ 6 from the nodular lesion on www.nature.com/bmt the shin showed the presence of similar organisms ( Figure 2b ). As the patient had persistent fever, liposomal amphotericin-B (3 mg/kg i.v.) daily was administered on day þ 9. The patient responded to the above treatment, became afebrile on day þ 15 and the skin lesions gradually resolved. He received liposomal amphotericin-B for a total of 12 days, and voriconazole (p.o.) was continued for the next 2 months on an outpatient basis. This is probably the first case report of A. pullulans fungemia after allogeneic stem cell transplant to our knowledge. In our case, the blood culture initially grew yeast-like colonies suggestive of Candida species. However, on subculture, the characteristic colony morphology (moist and creamy colonies in 2 days, which matured into shiny brownish black colonies with a gray fringe and pigment production) was suggestive of A. pullulans fungemia. The source of fungemia in this patient was the central venous catheter.
A. pullulans is a very rare cause of systemic infection in humans. Reports have suggested that it may cause keratomycosis (corneal and scleral ulcer), meningitis, splenic abscess, jaw abscess, pulmonary mycosis, sepsis and other opportunistic infections, as well as cutaneous mycoses such as eumycotic dermatitis. 2 It has also been isolated from peritoneal fluids and central venous catheters, but when isolated from healthy subjects, it is considered as a contaminant. 3 Disseminated systemic infection as in our patient has been reported in only four cases so far. Of the four cases, one had AML, 4 the second patient had ovarian carcinoma 5 (both had Hickman catheters in situ), the third patient had met with a road traffic accident with accidental inoculation of pathogen 3 and the fourth was a child with congenital heart disease who had undergone closure of an atrial septal defect with a Goretex patch. 2 Cutaneous involvement by Aureobasidium is also rare, and on an extensive search of the literature we could find only two case reports in patients of kidney and liver transplant. 6, 7 There is no standard treatment for infection caused by A. pullulans because of the paucity of human cases reported in literature. Amphotericin-B alone or in combination with azoles has been tried with variable success. [3] [4] [5] 8, 9 Combination therapy is probably the treatment of choice. The duration of treatment is not certain, though most patients received antifungal treatment for 4-8 weeks.
2,3 Our patient is now 5 months post second transplant and is doing well with no chronic sequelae of infection. 
